Significant Changes in Antipsychotic Drug Use during Pregnancy

Veterinary and Human Toxicology

Volumn 46, Issue 1, 2004, Pages 44-46

  McKenna, Kate ^a   Einarson, Adrienne ^b   Levinson, Andrea ^c   Koren, Gideon ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIMOZIDE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE;

ARTICLE; COMPARATIVE STUDY; DRUG USE; FEMALE; HUMAN; HYPERPROLACTINEMIA; INFERTILITY; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PREGNANCY; PUBLIC HEALTH;

ADULT; ANTIPSYCHOTIC AGENTS; COUNSELING; DRUG INFORMATION SERVICES; DRUG UTILIZATION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFERTILITY; MATERNAL EXPOSURE; MATERNAL HEALTH SERVICES; MENTAL DISORDERS; OFFICE VISITS; ONTARIO; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0347634359     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hermann RC, Yang D, Ettner SL et al: Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatr Serv 53:425-430, 2002.
2. Dewa CS, Remington G, Herrmann N et al: How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. Clin Ther 24:1466-1476, 2002.
3. Centorrino F, Eakin M, Bahk WM et al: Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry 159:1932-1935, 2002.
4. Dickson RA, Dawson DT: Olanzapine and pregnancy. Can J Psychiatry 43:196-197, 1998.
5. Kaplan B, Modai I, Stoler M et al: Clozapine treatment and risk of unplanned pregnancy. J Am Board Fam Pract 8:239-241, 1995.
6. Gregoire A, Pearson S: Risk of pregnancy when changing to atypical antipsychotics. Br J Psychiatry 180:83-84, 2002.
7. Beumont PJ, Gelder MG, Friesen GH et al: The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea. Br J Psychiatry 124: 413-419, 1974.
8. Smith SM, O'Keane V, Murray R: Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181:49-55, 2002.
9. Turrone P, Kapur S, Seeman MV et al: Elevation of prolactin levels by atypical antipsychotics. Am J Psychiatry 159:133-135, 2002.
10. Alexiadis M, Whitehorn D, Woodley H, et al.: Prolactin elevation with quetiapine. Am J Psychiatry 159:1608-1609, 2002.
11. Haverkamp F, Propping P, Hilger T: Is there an increase of reproductive rates in schizophrenics? I. Critical review of the literature. Arch Psychiatr Nervenkr 232:439-450, 1982.
12. Howard LM, Kumar C, Leese M et al: The general fertility rate in women with psychotic disorders. Am J Psychiatry 159:991-997, 2002.
13. McGrath JJ, Hearle J, Jenner L et al: The fertility and fecundity of patients with psychoses. Acta Psychiatr Scand 99:441-446, 1999.
14. Buckley PF: Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 50: 912-924, 2001.
15. Chernomas WM, Clarke DE, Chisholm FA: Perspectives of women living with schizophrenia. Psychiatr Serv 51:1517-1521, 2000.